Results 141 to 150 of about 32,609 (300)
Addiction, EarlyView.Abstract Background and aims Lower risk guidelines for safer levels of cannabis use could help to reduce the health burden posed by cannabis use disorder (CUD). We aimed to estimate risk thresholds for CUD based on delta‐9‐tetrahydrocannabinol (THC) consumption using standard THC units (1 unit = 5 mg THC).
Rachel Lees Thorne +9 more
wiley +1 more source
Student's Journal of Health Research AfricaMedical Cannabis sativa inflorescence has gained popularity in recent years due to the therapeutic pharmacological characteristics of its components. Cannabis sativa L.-based drugs are effective in treating a variety of illnesses, including constipation,
Sipho Goge +2 more
doaj +1 more source
Alternatives to prohibition illicit drugs: how we can stop killing and criminalising young Australians [PDF]
This report follows from a Roundtable discussion held in July 2012 to consider new approaches to public policy about illicit drugs in Australia. An earlier Australia21 report launched in April 2012 had concluded that attempts to control drug use through ...
Alex Wodak, Bob Douglas, David McDonald
core
Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era
Addiction, EarlyView.Abstract Background Canada's 2018 legalization of non‐medical cannabis was positioned as a public health initiative, intended to shift cannabis use from criminalization to regulation. Since then, cannabis access and consumption have grown significantly but the systems used to monitor cannabis‐related harms have not kept pace.
Anees Bahji
wiley +1 more source
Policy formation and debate concerning the government regulation of ayurveda in Great Britain in the twenty-first century [PDF]
, 2005 Since 2000, the British House of Lords and the Government have been working towards a regulatory scheme for Complementary and Alternative medicine in Britain, a scheme that will include ayurveda.The present paper discusses these regulatory moves by the ...
Wujastyk, D
core
Addiction, EarlyView.Abstract Background and aims Currently, there is no data‐driven cannabis reduction metric using biochemical verification, which represents a significant gap in cannabis harm reduction research, treatment and policy. Using aggregated data from 7 cannabis use disorder treatment trials, the aims of this analysis were to 1) determine if decreases in self ...
Erin A. McClure +6 more
wiley +1 more source
Varenicline for cannabis use disorder: A randomized controlled trial
Addiction, EarlyView.Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark +8 more
wiley +1 more source
Does the total consumption model apply to cannabis use?
Addiction, EarlyView.Abstract Aims To test whether the total consumption model and its extension, the theory of collectivity, apply to adolescent cannabis use. We estimated: (1) whether the distribution of cannabis use frequency was stable over time; (2) whether changes in average cannabis use were mirrored across consumption quantiles; and (3) whether higher average use ...
Thor Norström, Håkan Leifman
wiley +1 more source
Expanding Production of Cannabis in Iowa [PDF]
, 2015 Following passage of Senate Bill 2360 “Medical Cannabidiol Act” in Iowa, possession of Cannabidiol Oil become legal for patients who suffered from intractable epilepsy.
DeWall, Christine +4 more
core +1 more source